Preview

Humans and their health

Advanced search

Development of methods of chemical and toxicological analysis of Rifabutin in objects of biological origin

https://doi.org/10.21626/vestnik/2022-1/07

Abstract

Objective: to develop a technique for isolating and identifying rifabutin for chemical and toxicological analysis from biological material. Materials and methods. The substance rifabutin, capsules Farbutin containing rifabutin 150 mg, ethyl alcohol 95%, hydrochloric acid solution 0.1 M, sodium hydroxide solution 0.1 M, purified water, ammonia solution 10%, solutions of ammonium sulfate 20%, ammonium sulfate saturated, sodium sulfate 5%, sodium sulfate saturated, sodium chloride 20%, sodium chloride saturated were used for analysis. Organic solvents: benzene, dichloromethane, diethyl ether, toluene, chloroform, ethyl acetate. The pH was determined using a universal ionometer It-1101. Isolation was carried out by liquid-liquid extraction, detection and quantification by spectrophotometric method in the ultraviolet region. The optical density was measured using a SF-2000 spectrophotometer in cuvettes with a layer thickness of 1 cm. Results. In the course of the study, the optical properties of rifabutin, and absorption spectra characterized by two absorption bands at 231±2 nm and 279±2 nm were studied, ethyl alcohol 95% and hydrochloric acid solution 0.1 M, concentration 0.002% as optimal solvents were determined. The effect of various factors on the extraction of rifabutin from aqueous solutions has been experimentally studied. The highest degree of extraction is achieved by dichloromethane at pH 2, in the presence of sodium chloride saturated solution, once for 3 minutes. Conclusion. Methods of isolation and quantitative determination of rifabutin by UV spectrophotometry in extracts from biological fluids and organs have been developed.

References

1. State Pharmacopoeia of the Russian Federation. XIV edi-tion. Vol. I. Moscow: Federal electronic medical li-brary (in Russ.). URL: https://docs.rucml.ru/feml/pharma/v14/vol1

2. Kostanyan A.E., Safiulina A.M., Tananaev I.G., Myasoe-dov B.F. Multiphase extraction: design of single- and multistage separation using liquid pseudomembranes. Doklady Chemistry. 2005;404(4-6):203-205

3. Krivonos P.S.,. Avdeev G.S. Improving the effectiveness of tuberculosis chemotherapy in modern conditions. Immunopathology, allergology, infectology. 2000;(3):97-99 (in Russ.)

4. Kuznetsova I.G. Experimental study on the distribution of rifabutin in nanoscale tissues. Vestnik Moskovskogo Gosudarstvennogo Oblastnogo Gumanitarnogo Instituta. Seriya: mediko-biologicheskiye nauki. 2014;(2):42-45 (in Russ.)

5. Nechaeva O.B. Monitoring of tuberculosis and HIV-infection in Russian Federation. Medical alphabet. 2017;3(30):24-33 (in Russ.)

6. Blaschke T.F., Skinner M.H. The clinical pharmacokinetics of rifabutin. Clin Infect Dis. 1996; 22(Suppl 1):S15-21

7. Jamis-Dow C.A., Katki A.G., Collins J.M., Klecker R.W. Rifampin and rifabutin and their metabolism by human liver esterases. Xenobiotica. 1997;27(10):1015-1024. DOI: 10.1080/004982597239994

8. Ji B., Truffot-Pernot C., Lacroix C., Raviglione M.C., O'Brien R.J., Olliaro P., Roscigno G., Grosset J. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis. 1993;148(6 Pt 1):1541-1546. DOI: 10.1164/ajrccm/148.6_Pt_1.1541

9. Lau Y.Y., Hanson G.D., Carel B.J. Determination of rifabutin in human plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Appl. 1996;676(1):125-130. DOI: 10.1016/0378-4347(95)00423-8

10. Lewis R.C., Hatfield N.Z., Narang P.K. A sensitive method for quantitation of rifabutin and its desacetyl metabolite in human biological fluids by high-performance liquid chromatography (HPLC). Pharm Res. 1991;8(11):1434-1440. DOI: 10.1023/a:1015865526655

11. Li R.C., Narang P.K., Poggesi I., Strolin-Benedetti M. A model based assessment of redistribution dependent elimination and bioavailability of rifabutin. Biopharm Drug Dispos. 1996;17(3):223-236. DOI: 10.1002/(SICI)1099-081X(199604)17:3<223::AID-BDD954>3.0.CO;2-S

12. Skinner M.H., Hsieh M., Torseth J., Pauloin D., Bhatia G., Harkonen S., Merigan T.C., Blaschke T.F. Pharmacokinetics of rifabutin. Antimicrob Agents Chemother. 1989;33(8):1237-1241. DOI: 10.1128/AAC.33.8.1237

13. Utkin I., Koudriakova T., Thompson T., Cottrell C., Iatsimirskaia E., Barry J., Vouros P., Gerber N. Isolation and identification of major urinary metabolites of rifabutin in rats and humans. Drug Metab Dispos. 1997;25(8):963-969


Review

For citations:


Konovalova S.S., Illarionova E.A. Development of methods of chemical and toxicological analysis of Rifabutin in objects of biological origin. Humans and their health. 2022;25(1):54-61. (In Russ.) https://doi.org/10.21626/vestnik/2022-1/07

Views: 269


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1998-5746 (Print)
ISSN 1998-5754 (Online)